查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
2088211

獸用抗生素和抗菌劑市場：按類型、動物種類、給藥途徑、劑型、最終用戶和配銷通路分類－2026-2032年全球市場預測

Animal Antibiotics & Antimicrobials Market by Class, Animal Species, Administration Route, Formulation, End User, Distribution Channel - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 180 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，動物抗生素和抗菌劑市場將成長至 74.1 億美元，複合年成長率為 7.08%。

主要市場統計數據
基準年 2025 45.9億美元
預計年份：2026年 48.7億美元
預測年份 2032 74.1億美元
複合年成長率 (%) 7.08%

獸用抗生素和抗菌劑市場概覽

獸用抗生素和抗菌劑對獸醫學、肉類動物的生產力以及伴侶動物的健康仍然至關重要，但抗菌素抗藥性的出現、對更嚴格、更合理使用的期望以及消費者對負責任生產的蛋白質的需求變化，正在重新定義它們的作用。該市場涵蓋了具有重要醫學價值的抗生素、離子載體、磺胺類藥物、四環素類藥物、磺胺類藥物、BETA-內醯胺類藥物、四環黴素以及其他獸用抗菌劑，這些藥物在受監管的條件下用於治療、控制和預防牲畜、家禽、Fluoroquinolones和寵物的細菌性疾病。

獸用抗菌藥物領域的變革性變化

獸用抗生素領域正從基於劑量的給藥方式轉向基於實證醫學的按需治療。在美國，FDA的政策已將用於生產目的的具有重要醫療價值的抗生素從飼料和飲用水標籤中移除，並將剩餘的治療用途置於獸醫的監管之下。在歐盟，法律禁止使用促進生長抗生素，並限制常規預防性用藥，強化了市場向負責任處方和農場層級預防的方向發展。

人工智慧對獸醫抗生素管理的累積影響

人工智慧（AI）並非取代獸醫的判斷，而是成為輔助合理使用抗生素的實用工具。人工智慧驅動的疾病監測整合了農場記錄、生產數據、環境訊號、檢測結果和治療史，以便及早發現異常疾病模式。這使得獸醫能夠更有針對性地進行檢測，隔離受影響群體，並減少不必要的團體治療。

獸用抗生素和抗菌藥物的關鍵區域見解

由於亞太地區畜牧業規模大規模、家禽和水產養殖業快速發展，以及各國對抗生素抗藥性的監管日益關注，該地區已成為重點區域。中國、印度、日本、韓國和澳洲等國正在以不同的速度發展監測系統、獸醫監管和殘留控制系統，這催生了對受監管的獸用抗生素、獸用抗菌劑、診斷試劑和支持合理使用的農場管理工具的需求。

針對東協、海灣合作理事會、歐盟、金磚國家、七國集團和北約的關鍵群體特定見解

隨著各國政府推動獸醫法規和食品安全體系的現代化，東協市場在禽類、生豬和水產養殖的衛生管理方面日益重要。該地區的商業機會與實際的應用模式息息相關，這些模式既適用於小規模農戶，也適用於綜合性生產商和出口型生產商。金磚國家在全球動物性蛋白質生產和需求中佔據重要佔有率，巴西、中國、印度和俄羅斯亟需可擴展的疾病控制策略，以在提高生產力的同時降低抗生素抗藥性。

各國獸用抗生素和抗菌藥物的關鍵訊息

美國在獸醫監管、伴侶動物照護以及受監管的牲畜抗菌藥物的使用方面處於主導地位，其FDA的管理政策對市場准入有著重要影響。加拿大也採取了類似的謹慎使用政策，但鑑於墨西哥在北美牛肉、豬肉和家禽貿易中的重要地位，遵守殘留限量和疾病控制至關重要。巴西是全球最具影響力的動物性蛋白質出口國之一，獸用抗菌藥物、生物安全和合規系統對於其在禽肉、牛肉和豬肉領域保持競爭力至關重要。

為行業領導者提供的實用建議

行業領導者應優先考慮符合獸醫監管、抗藥性風險管理和已記錄的治療需求的產品系列。這包括在適當情況下投資窄頻譜藥物、明確標籤檢視、加強藥物安全監測，並透過藥敏試驗、治療方案和數位化病歷管理為獸醫提供支援。

調查方法

本研究的方法基於一個綜合框架，該框架利用了公共衛生、獸醫學、監管和貿易方面的檢驗資訊來源。主要參考資料包括世界衛生組織（WHO）、世界動物衛生組織（OIE）、聯合國糧食及農業組織（FAO）、各國獸醫主管機關、美國食品藥物管理局（FDA）、歐洲藥品管理局（EMA）以及區域抗菌素抗藥性計畫的指導和監測架構。

結論

獸用抗生素和抗菌劑市場正進入一個更規範化的階段，其成長如今取決於負責任的用藥途徑、可衡量的療效以及與全球抗菌素抗藥性優先事項的契合。雖然治療性抗菌劑對於動物福利和食品安全仍然至關重要，但其使用將擴大受到診斷、監測、獸醫批准以及以預防為優先的畜群健康策略的驅動。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 市場動態
  • 波特五力分析
  • PESTLE分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：人工智慧的累積影響，2026年

第7章：獸用抗生素和抗菌劑市場：依分類

  • Aminoglycosides抗生素
    • 慶大霉素
    • 新黴素
    • 鏈黴素
  • BETA-內醯胺
    • 頭孢菌素
    • 青黴素
  • Fluoroquinolones
    • Ciprofloxacin
    • 恩諾沙星
    • 馬波沙星
  • 大環內酯類
    • 紅黴素
    • 螺旋黴素
    • 替爾米科辛
    • 泰樂菌素
  • 磺胺類藥物藥物
    • 磺胺二甲氧嗪
    • 磺胺二甲嗪
  • 四環黴素
    • 四環黴素
    • 多西環素
    • 四環黴素
    • 四環黴素

第8章：獸用抗生素和抗菌劑市場：依動物種類分類

  • 水產養殖
  • 牛
  • 伴侶動物
  • 家禽
  • 豬

第9章：獸用抗生素和抗菌劑市場：依給藥途徑分類

  • 飼料添加劑
  • 卵內給藥
  • 注射藥物
  • 口服
  • 外用
  • 水溶性

第10章：獸用抗生素和抗菌劑市場：依劑型分類

  • Bolus
  • 液體
  • 粉末
  • 預混合料

第11章：獸用抗生素和抗菌劑市場：依最終用戶分類

  • 商業農場
  • 獸醫醫院和診所
  • 研究機構

第12章：獸用抗生素和抗菌劑市場：依分銷管道分類

  • 離線
  • 線上

第13章：獸用抗生素和抗菌劑市場：依地區分類

  • 亞太地區
  • 北美洲
  • 拉丁美洲
  • 歐洲
  • 中東
  • 非洲

第14章：獸用抗生素和抗菌劑市場：依類別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第15章：獸用抗生素和抗菌劑市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年

第17章：公司簡介

  • AdvaCare Pharma LLP
  • Ashish Life Science Private Limited
  • Bayer AG
  • Bimeda Holdings Limited
  • Boehringer Ingelheim International GmbH
  • Ceva Sante Animale SA
  • China Animal Husbandry Industry Co., Ltd
  • Dechra Pharmaceuticals PLC
  • ECO Animal Health Group Plc
  • Elanco Animal Health Incorporated
  • Endovac Animal Health
  • Hester Biosciences Limited
  • HIPRA SA
  • Huvepharma EOOD
  • Indian Immunologicals Ltd
  • Inovet Group
  • Intas Animal Health
  • Kyoritsu Seiyaku Corporation
  • Lutim Pharma Pvt Ltd
  • Meiji Holdings Co., Ltd
  • Merck & Co., Inc
  • Norbrook Laboratories Limited
  • Ouro Fino Saude Animal
  • Phibro Animal Health Corporation
  • SeQuent Scientific Ltd
  • Vetoquinol SA
  • Vetsfarma Ltd
  • Virbac SA
  • Zoetis Inc
  • Zydus Animal Health And Investments Limited
Product Code: MRR-031BF22F949D

The Animal Antibiotics & Antimicrobials Market is projected to grow by USD 7.41 billion at a CAGR of 7.08% by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 4.59 billion
Estimated Year [2026] USD 4.87 billion
Forecast Year [2032] USD 7.41 billion
CAGR (%) 7.08%

Animal Antibiotics & Antimicrobials Market Introduction

Animal antibiotics and antimicrobials remain essential to veterinary medicine, food-animal productivity, and companion-animal health, but their role is being redefined by antimicrobial resistance, tighter stewardship expectations, and changing consumer demand for responsibly produced protein. The market spans medically important antibiotics, ionophores, sulfonamides, tetracyclines, macrolides, beta-lactams, fluoroquinolones, and other veterinary antimicrobial classes used under regulated conditions to treat, control, and prevent bacterial disease in livestock, poultry, aquaculture, and pets.

The sector is now shaped by a clear public-health mandate: preserve antimicrobial effectiveness while sustaining animal welfare and food security. WHO identifies antimicrobial resistance as one of the top global public-health threats, while WOAH, FAO, and national regulators continue to promote surveillance, veterinary oversight, responsible prescribing, and prudent-use frameworks. As a result, growth opportunities are increasingly tied to prescription-based access, diagnostics-led treatment, residue compliance, farm biosecurity, and alternatives that reduce disease pressure without undermining therapeutic availability.

Transformative Shifts in the Animal Antimicrobials Landscape

The animal antimicrobials landscape is shifting from volume-led medication toward evidence-based, need-specific therapy. In the United States, FDA policy removed production uses of medically important antimicrobials from feed and water labels and brought remaining therapeutic uses under veterinary oversight. In the European Union, legislation prohibits antibiotic growth promotion and restricts routine prophylaxis, reinforcing a market direction centered on accountable prescribing and farm-level prevention.

At the same time, producers face persistent disease risks from intensive farming, climate-linked pathogen pressure, cross-border animal movement, and expanding aquaculture. These conditions are accelerating demand for rapid diagnostics, vaccination programs, precision dosing, traceability systems, and integrated herd-health services. Suppliers that combine compliant antimicrobial portfolios with stewardship support, residue management, and outcome-based veterinary guidance are better positioned than those relying on undifferentiated product access.

Cumulative Impact of Artificial Intelligence on Veterinary Antimicrobials

Artificial intelligence is becoming a practical enabler of antimicrobial stewardship rather than a replacement for veterinary judgment. AI-supported disease surveillance can combine farm records, production data, environmental signals, laboratory results, and treatment history to detect abnormal morbidity patterns earlier. This helps veterinarians target testing, isolate affected groups, and reduce unnecessary blanket treatment.

AI is also improving antimicrobial decision support through predictive analytics, resistance-pattern monitoring, image-based diagnostics, and optimization of dosage and withdrawal-period compliance. In research and development, machine learning is used to screen antimicrobial candidates, evaluate combinations, and identify resistance markers. The most immediate commercial value lies in AI-enabled precision livestock management: fewer treatment failures, better documentation, stronger audit readiness, and more defensible antibiotic use across complex supply chains.

Key Regional Insights for Animal Antibiotics & Antimicrobials

Asia-Pacific is a high-priority region because it combines large livestock populations, fast-growing poultry and aquaculture industries, and increasing regulatory attention to antimicrobial resistance. China, India, Japan, South Korea, and Australia are advancing surveillance, veterinary oversight, and residue-control systems at different speeds, creating demand for compliant animal antibiotics, veterinary antimicrobials, diagnostics, and farm-management tools that support responsible use.

North America is defined by mature veterinary distribution, strong food-safety enforcement, and established prescription oversight. The United States and Canada continue to emphasize medically important antimicrobial stewardship, while Mexico remains important for integrated North American protein supply chains. Latin America, led by Brazil and Mexico, balances export-driven residue compliance with high disease-management needs in cattle, poultry, and swine, making biosecurity, therapeutic reliability, and regulatory documentation central to market participation.

Europe is among the strictest regulatory environments, with EU rules shaping reduced routine use, stronger monitoring, and preference for prevention-led animal health. The Middle East is investing in food security, dairy, poultry, and camel health, while GCC countries are strengthening import standards and veterinary infrastructure. Africa presents long-term potential due to herd expansion and food-security needs, but market development depends on veterinary access, cold-chain reliability, diagnostics capacity, residue monitoring, and control of informal antimicrobial channels.

Key Group Insights Across ASEAN, GCC, EU, BRICS, G7, and NATO

ASEAN markets are increasingly important for poultry, swine, and aquaculture health as governments modernize veterinary regulation and food-safety systems. The region's opportunity is tied to practical stewardship models that work across smallholders, integrators, and export-oriented producers. BRICS countries represent a major share of global animal protein production and demand, with Brazil, China, India, and Russia requiring scalable disease-control strategies that align productivity with antimicrobial resistance mitigation.

The European Union remains a benchmark for antimicrobial governance through harmonized restrictions, surveillance, and farm-to-fork policy alignment. G7 countries influence global standards through advanced research, pharmaceutical regulation, One Health antimicrobial resistance action plans, and veterinary innovation, while NATO members overlap with many high-income markets where supply-chain resilience, biosecurity, and food-system security have gained strategic importance. GCC markets are smaller in livestock volume than Asia-Pacific or Latin America, but they are strategically relevant because of food-security investment, premium dairy and poultry operations, import dependence, and rising expectations for regulated veterinary care.

Key Country Insights for Animal Antibiotics & Antimicrobials

The United States leads in veterinary oversight, companion-animal care, and regulated livestock antimicrobial use, with FDA stewardship policies shaping market access. Canada follows a similar prudent-use direction, while Mexico's role in North American beef, pork, and poultry trade makes residue compliance and disease control central. Brazil is one of the world's most influential animal-protein exporters, making veterinary antimicrobials, biosecurity, and compliance systems critical to poultry, beef, and swine competitiveness.

In Europe, the United Kingdom, Germany, France, Italy, and Spain operate under mature veterinary frameworks with strong attention to antimicrobial reduction, monitoring, and prevention. Germany and France emphasize high-standard veterinary medicine and livestock productivity, while Spain and Italy remain significant livestock and companion-animal markets. Russia has substantial poultry, swine, and cattle production needs, with domestic supply resilience, veterinary access, and disease surveillance influencing market behavior.

China and India are pivotal because of scale, livestock diversity, and rising demand for safe animal protein. China continues to strengthen veterinary regulation and food-safety enforcement, while India's dairy, poultry, and aquaculture sectors require accessible veterinary solutions and responsible-use education. Japan and South Korea are advanced, quality-focused markets with strong regulatory expectations and sophisticated livestock and companion-animal care systems. Australia combines export-oriented livestock production with strict biosecurity and residue standards, supporting demand for compliant therapeutics and antimicrobial stewardship tools.

Actionable Recommendations for Industry Leaders

Industry leaders should prioritize portfolios that align with veterinary oversight, resistance-risk management, and documented therapeutic need. This includes investing in narrow-spectrum options where appropriate, improving label clarity, strengthening pharmacovigilance, and supporting veterinarians with susceptibility testing, treatment protocols, and digital recordkeeping.

Organizations should also build growth beyond the molecule by integrating diagnostics, vaccines, biosecurity advisory services, microbiome-support solutions, and precision-farming platforms. Market access teams need region-specific compliance strategies, especially for EU restrictions, FDA requirements, export residue standards, and emerging-market stewardship programs. Partnerships with laboratories, producer groups, universities, and regulators can improve evidence generation and reinforce trust with retailers, food companies, veterinarians, producers, and consumers.

Research Methodology

The research approach is grounded in a comprehensive framework that leverages verified public-health, veterinary, regulatory, and trade sources. Core references include guidance and surveillance frameworks from the World Health Organization, the World Organisation for Animal Health, the Food and Agriculture Organization, national veterinary authorities, the U.S. Food and Drug Administration, the European Medicines Agency, and regional antimicrobial resistance action plans.

The analysis triangulates regulatory developments, animal-production trends, antimicrobial stewardship policies, veterinary distribution dynamics, food-safety requirements, residue-control expectations, and disease-management needs across regions and countries. Insights are evaluated for commercial relevance, policy consistency, and applicability to animal antibiotics and antimicrobials, with an emphasis on evidence-backed themes rather than unsupported market-size, market-share, or forecasting claims.

Conclusion

The animal antibiotics and antimicrobials market is entering a more disciplined phase in which growth depends on responsible access, measurable outcomes, and alignment with global antimicrobial resistance priorities. Therapeutic antimicrobials will remain indispensable for animal welfare and food security, but their use will be increasingly guided by diagnostics, surveillance, veterinary authorization, and prevention-first herd-health strategies.

Manufacturers, distributors, veterinarians, and producers that embrace stewardship as a commercial advantage can strengthen market resilience. The strongest opportunities will come from compliant antimicrobial portfolios, AI-enabled decision support, regional regulatory expertise, and integrated solutions that reduce disease burden while preserving the effectiveness of critical veterinary medicines.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Market Dynamics
    • 4.3.1. Key Drivers
    • 4.3.2. Key Restraints
    • 4.3.3. Key Opportunities
    • 4.3.4. Key Challenges
  • 4.4. Porter's Five Forces Analysis
  • 4.5. PESTLE Analysis
  • 4.6. Market Outlook
    • 4.6.1. Near-Term Market Outlook (0-2 Years)
    • 4.6.2. Medium-Term Market Outlook (3-5 Years)
    • 4.6.3. Long-Term Market Outlook (5-10 Years)
  • 4.7. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Animal Antibiotics & Antimicrobials Market, by Class

  • 7.1. Aminoglycosides
    • 7.1.1. Gentamicin
    • 7.1.2. Neomycin
    • 7.1.3. Streptomycin
  • 7.2. Beta Lactams
    • 7.2.1. Cephalosporins
    • 7.2.2. Penicillins
  • 7.3. Fluoroquinolones
    • 7.3.1. Ciprofloxacin
    • 7.3.2. Enrofloxacin
    • 7.3.3. Marbofloxacin
  • 7.4. Macrolides
    • 7.4.1. Erythromycin
    • 7.4.2. Spiramycin
    • 7.4.3. Tilmicosin
    • 7.4.4. Tylosin
  • 7.5. Sulfonamides
    • 7.5.1. Sulfadimethoxine
    • 7.5.2. Sulfamethazine
  • 7.6. Tetracyclines
    • 7.6.1. Chlortetracycline
    • 7.6.2. Doxycycline
    • 7.6.3. Oxytetracycline
    • 7.6.4. Tetracycline

8. Animal Antibiotics & Antimicrobials Market, by Animal Species

  • 8.1. Aquaculture
  • 8.2. Cattle
  • 8.3. Companion Animals
  • 8.4. Poultry
  • 8.5. Swine

9. Animal Antibiotics & Antimicrobials Market, by Administration Route

  • 9.1. Feed Additives
  • 9.2. In Ovo
  • 9.3. Injectable
  • 9.4. Oral
  • 9.5. Topical
  • 9.6. Water Soluble

10. Animal Antibiotics & Antimicrobials Market, by Formulation

  • 10.1. Bolus
  • 10.2. Liquid
  • 10.3. Powder
  • 10.4. Premix

11. Animal Antibiotics & Antimicrobials Market, by End User

  • 11.1. Commercial Farms
  • 11.2. Veterinary Hospitals & Clinics
  • 11.3. Research Institutions

12. Animal Antibiotics & Antimicrobials Market, by Distribution Channel

  • 12.1. Offline
  • 12.2. Online

13. Animal Antibiotics & Antimicrobials Market, by Region

  • 13.1. Asia-Pacific
  • 13.2. North America
  • 13.3. Latin America
  • 13.4. Europe
  • 13.5. Middle East
  • 13.6. Africa

14. Animal Antibiotics & Antimicrobials Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Animal Antibiotics & Antimicrobials Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. Competitive Landscape

  • 16.1. Market Concentration Analysis, 2025
    • 16.1.1. Concentration Ratio (CR)
    • 16.1.2. Herfindahl Hirschman Index (HHI)
  • 16.2. Recent Developments & Impact Analysis, 2025
  • 16.3. Product Portfolio Analysis, 2025
  • 16.4. Benchmarking Analysis, 2025

17. Company Profiles

  • 17.1. AdvaCare Pharma LLP
  • 17.2. Ashish Life Science Private Limited
  • 17.3. Bayer AG
  • 17.4. Bimeda Holdings Limited
  • 17.5. Boehringer Ingelheim International GmbH
  • 17.6. Ceva Sante Animale S.A.
  • 17.7. China Animal Husbandry Industry Co., Ltd
  • 17.8. Dechra Pharmaceuticals PLC
  • 17.9. ECO Animal Health Group Plc
  • 17.10. Elanco Animal Health Incorporated
  • 17.11. Endovac Animal Health
  • 17.12. Hester Biosciences Limited
  • 17.13. HIPRA S.A.
  • 17.14. Huvepharma EOOD
  • 17.15. Indian Immunologicals Ltd
  • 17.16. Inovet Group
  • 17.17. Intas Animal Health
  • 17.18. Kyoritsu Seiyaku Corporation
  • 17.19. Lutim Pharma Pvt Ltd
  • 17.20. Meiji Holdings Co., Ltd
  • 17.21. Merck & Co., Inc
  • 17.22. Norbrook Laboratories Limited
  • 17.23. Ouro Fino Saude Animal
  • 17.24. Phibro Animal Health Corporation
  • 17.25. SeQuent Scientific Ltd
  • 17.26. Vetoquinol S.A.
  • 17.27. Vetsfarma Ltd
  • 17.28. Virbac S.A.
  • 17.29. Zoetis Inc
  • 17.30. Zydus Animal Health And Investments Limited

LIST OF FIGURES

  • FIGURE 1. GLOBAL ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET, YEARS CONSIDERED FOR THE STUDY
  • FIGURE 2. GLOBAL ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET, RESEARCH DESIGN
  • FIGURE 3. GLOBAL ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET, RESEARCH FRAMEWORK
  • FIGURE 4. GLOBAL ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET, DATA TRIANGULATION
  • FIGURE 5. GLOBAL ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 6. GLOBAL ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 7. GLOBAL ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 8. GLOBAL ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY CLASS, 2025 VS 2032 (%)
  • FIGURE 9. GLOBAL ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY CLASS, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY ANIMAL SPECIES, 2025 VS 2032 (%)
  • FIGURE 11. GLOBAL ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY ANIMAL SPECIES, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY ADMINISTRATION ROUTE, 2025 VS 2032 (%)
  • FIGURE 13. GLOBAL ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY ADMINISTRATION ROUTE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FORMULATION, 2025 VS 2032 (%)
  • FIGURE 15. GLOBAL ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FORMULATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 16. GLOBAL ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY END USER, 2025 VS 2032 (%)
  • FIGURE 17. GLOBAL ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 18. GLOBAL ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2032 (%)
  • FIGURE 19. GLOBAL ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 20. GLOBAL ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY REGION, 2025 VS 2032 (%)
  • FIGURE 21. GLOBAL ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 22. GLOBAL ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
  • FIGURE 23. GLOBAL ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 24. GLOBAL ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
  • FIGURE 25. GLOBAL ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY CLASS, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL GENTAMICIN MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL GENTAMICIN MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL GENTAMICIN MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL NEOMYCIN MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL NEOMYCIN MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL NEOMYCIN MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL STREPTOMYCIN MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL STREPTOMYCIN MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL STREPTOMYCIN MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL BETA LACTAMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL BETA LACTAMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL BETA LACTAMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL CEPHALOSPORINS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL CEPHALOSPORINS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL CEPHALOSPORINS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL PENICILLINS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL PENICILLINS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL PENICILLINS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL FLUOROQUINOLONES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL FLUOROQUINOLONES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL FLUOROQUINOLONES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL CIPROFLOXACIN MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL CIPROFLOXACIN MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL CIPROFLOXACIN MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL ENROFLOXACIN MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL ENROFLOXACIN MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL ENROFLOXACIN MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL MARBOFLOXACIN MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL MARBOFLOXACIN MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL MARBOFLOXACIN MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL MACROLIDES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL MACROLIDES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL MACROLIDES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL ERYTHROMYCIN MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL ERYTHROMYCIN MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL ERYTHROMYCIN MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL SPIRAMYCIN MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL SPIRAMYCIN MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL SPIRAMYCIN MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL TILMICOSIN MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL TILMICOSIN MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL TILMICOSIN MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL TYLOSIN MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL TYLOSIN MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL TYLOSIN MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL SULFONAMIDES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL SULFONAMIDES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL SULFONAMIDES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL SULFADIMETHOXINE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL SULFADIMETHOXINE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL SULFADIMETHOXINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL SULFAMETHAZINE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL SULFAMETHAZINE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL SULFAMETHAZINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL TETRACYCLINES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL TETRACYCLINES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL TETRACYCLINES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL CHLORTETRACYCLINE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL CHLORTETRACYCLINE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL CHLORTETRACYCLINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL DOXYCYCLINE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL DOXYCYCLINE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL DOXYCYCLINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL OXYTETRACYCLINE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL OXYTETRACYCLINE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL OXYTETRACYCLINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL TETRACYCLINE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL TETRACYCLINE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL TETRACYCLINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY ANIMAL SPECIES, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL AQUACULTURE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL AQUACULTURE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL AQUACULTURE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL CATTLE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL CATTLE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL CATTLE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL COMPANION ANIMALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL COMPANION ANIMALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL COMPANION ANIMALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL POULTRY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL POULTRY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL POULTRY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL SWINE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL SWINE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL SWINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL FEED ADDITIVES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL FEED ADDITIVES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL FEED ADDITIVES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL IN OVO MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL IN OVO MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL IN OVO MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL INJECTABLE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL INJECTABLE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL INJECTABLE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL ORAL MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL ORAL MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL ORAL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL TOPICAL MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL TOPICAL MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL TOPICAL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL WATER SOLUBLE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL WATER SOLUBLE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL WATER SOLUBLE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL BOLUS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 112. GLOBAL BOLUS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 113. GLOBAL BOLUS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 114. GLOBAL LIQUID MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 115. GLOBAL LIQUID MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 116. GLOBAL LIQUID MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 117. GLOBAL POWDER MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 118. GLOBAL POWDER MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 119. GLOBAL POWDER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 120. GLOBAL PREMIX MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 121. GLOBAL PREMIX MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 122. GLOBAL PREMIX MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 123. GLOBAL ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 124. GLOBAL COMMERCIAL FARMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 125. GLOBAL COMMERCIAL FARMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 126. GLOBAL COMMERCIAL FARMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 127. GLOBAL VETERINARY HOSPITALS & CLINICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 128. GLOBAL VETERINARY HOSPITALS & CLINICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 129. GLOBAL VETERINARY HOSPITALS & CLINICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 130. GLOBAL RESEARCH INSTITUTIONS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 131. GLOBAL RESEARCH INSTITUTIONS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 132. GLOBAL RESEARCH INSTITUTIONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 133. GLOBAL ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 134. GLOBAL OFFLINE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 135. GLOBAL OFFLINE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 136. GLOBAL OFFLINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 137. GLOBAL ONLINE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 138. GLOBAL ONLINE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 139. GLOBAL ONLINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 140. GLOBAL ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 141. ASIA-PACIFIC ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 142. ASIA-PACIFIC ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY CLASS, 2018-2032 (USD MILLION)
  • TABLE 143. ASIA-PACIFIC ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY AMINOGLYCOSIDES, 2018-2032 (USD MILLION)
  • TABLE 144. ASIA-PACIFIC ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY BETA LACTAMS, 2018-2032 (USD MILLION)
  • TABLE 145. ASIA-PACIFIC ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FLUOROQUINOLONES, 2018-2032 (USD MILLION)
  • TABLE 146. ASIA-PACIFIC ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY MACROLIDES, 2018-2032 (USD MILLION)
  • TABLE 147. ASIA-PACIFIC ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY SULFONAMIDES, 2018-2032 (USD MILLION)
  • TABLE 148. ASIA-PACIFIC ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY TETRACYCLINES, 2018-2032 (USD MILLION)
  • TABLE 149. ASIA-PACIFIC ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY ANIMAL SPECIES, 2018-2032 (USD MILLION)
  • TABLE 150. ASIA-PACIFIC ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2032 (USD MILLION)
  • TABLE 151. ASIA-PACIFIC ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 152. ASIA-PACIFIC ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 153. ASIA-PACIFIC ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 154. NORTH AMERICA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 155. NORTH AMERICA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY CLASS, 2018-2032 (USD MILLION)
  • TABLE 156. NORTH AMERICA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY AMINOGLYCOSIDES, 2018-2032 (USD MILLION)
  • TABLE 157. NORTH AMERICA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY BETA LACTAMS, 2018-2032 (USD MILLION)
  • TABLE 158. NORTH AMERICA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FLUOROQUINOLONES, 2018-2032 (USD MILLION)
  • TABLE 159. NORTH AMERICA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY MACROLIDES, 2018-2032 (USD MILLION)
  • TABLE 160. NORTH AMERICA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY SULFONAMIDES, 2018-2032 (USD MILLION)
  • TABLE 161. NORTH AMERICA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY TETRACYCLINES, 2018-2032 (USD MILLION)
  • TABLE 162. NORTH AMERICA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY ANIMAL SPECIES, 2018-2032 (USD MILLION)
  • TABLE 163. NORTH AMERICA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2032 (USD MILLION)
  • TABLE 164. NORTH AMERICA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 165. NORTH AMERICA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 166. NORTH AMERICA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 167. LATIN AMERICA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 168. LATIN AMERICA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY CLASS, 2018-2032 (USD MILLION)
  • TABLE 169. LATIN AMERICA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY AMINOGLYCOSIDES, 2018-2032 (USD MILLION)
  • TABLE 170. LATIN AMERICA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY BETA LACTAMS, 2018-2032 (USD MILLION)
  • TABLE 171. LATIN AMERICA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FLUOROQUINOLONES, 2018-2032 (USD MILLION)
  • TABLE 172. LATIN AMERICA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY MACROLIDES, 2018-2032 (USD MILLION)
  • TABLE 173. LATIN AMERICA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY SULFONAMIDES, 2018-2032 (USD MILLION)
  • TABLE 174. LATIN AMERICA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY TETRACYCLINES, 2018-2032 (USD MILLION)
  • TABLE 175. LATIN AMERICA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY ANIMAL SPECIES, 2018-2032 (USD MILLION)
  • TABLE 176. LATIN AMERICA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2032 (USD MILLION)
  • TABLE 177. LATIN AMERICA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 178. LATIN AMERICA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 179. LATIN AMERICA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 180. EUROPE ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 181. EUROPE ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY CLASS, 2018-2032 (USD MILLION)
  • TABLE 182. EUROPE ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY AMINOGLYCOSIDES, 2018-2032 (USD MILLION)
  • TABLE 183. EUROPE ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY BETA LACTAMS, 2018-2032 (USD MILLION)
  • TABLE 184. EUROPE ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FLUOROQUINOLONES, 2018-2032 (USD MILLION)
  • TABLE 185. EUROPE ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY MACROLIDES, 2018-2032 (USD MILLION)
  • TABLE 186. EUROPE ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY SULFONAMIDES, 2018-2032 (USD MILLION)
  • TABLE 187. EUROPE ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY TETRACYCLINES, 2018-2032 (USD MILLION)
  • TABLE 188. EUROPE ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY ANIMAL SPECIES, 2018-2032 (USD MILLION)
  • TABLE 189. EUROPE ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2032 (USD MILLION)
  • TABLE 190. EUROPE ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 191. EUROPE ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 192. EUROPE ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 193. MIDDLE EAST ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 194. MIDDLE EAST ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY CLASS, 2018-2032 (USD MILLION)
  • TABLE 195. MIDDLE EAST ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY AMINOGLYCOSIDES, 2018-2032 (USD MILLION)
  • TABLE 196. MIDDLE EAST ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY BETA LACTAMS, 2018-2032 (USD MILLION)
  • TABLE 197. MIDDLE EAST ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FLUOROQUINOLONES, 2018-2032 (USD MILLION)
  • TABLE 198. MIDDLE EAST ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY MACROLIDES, 2018-2032 (USD MILLION)
  • TABLE 199. MIDDLE EAST ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY SULFONAMIDES, 2018-2032 (USD MILLION)
  • TABLE 200. MIDDLE EAST ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY TETRACYCLINES, 2018-2032 (USD MILLION)
  • TABLE 201. MIDDLE EAST ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY ANIMAL SPECIES, 2018-2032 (USD MILLION)
  • TABLE 202. MIDDLE EAST ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2032 (USD MILLION)
  • TABLE 203. MIDDLE EAST ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 204. MIDDLE EAST ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 205. MIDDLE EAST ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 206. AFRICA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 207. AFRICA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY CLASS, 2018-2032 (USD MILLION)
  • TABLE 208. AFRICA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY AMINOGLYCOSIDES, 2018-2032 (USD MILLION)
  • TABLE 209. AFRICA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY BETA LACTAMS, 2018-2032 (USD MILLION)
  • TABLE 210. AFRICA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FLUOROQUINOLONES, 2018-2032 (USD MILLION)
  • TABLE 211. AFRICA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY MACROLIDES, 2018-2032 (USD MILLION)
  • TABLE 212. AFRICA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY SULFONAMIDES, 2018-2032 (USD MILLION)
  • TABLE 213. AFRICA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY TETRACYCLINES, 2018-2032 (USD MILLION)
  • TABLE 214. AFRICA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY ANIMAL SPECIES, 2018-2032 (USD MILLION)
  • TABLE 215. AFRICA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2032 (USD MILLION)
  • TABLE 216. AFRICA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 217. AFRICA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 218. AFRICA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 219. GLOBAL ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 220. ASEAN ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 221. ASEAN ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY CLASS, 2018-2032 (USD MILLION)
  • TABLE 222. ASEAN ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY AMINOGLYCOSIDES, 2018-2032 (USD MILLION)
  • TABLE 223. ASEAN ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY BETA LACTAMS, 2018-2032 (USD MILLION)
  • TABLE 224. ASEAN ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FLUOROQUINOLONES, 2018-2032 (USD MILLION)
  • TABLE 225. ASEAN ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY MACROLIDES, 2018-2032 (USD MILLION)
  • TABLE 226. ASEAN ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY SULFONAMIDES, 2018-2032 (USD MILLION)
  • TABLE 227. ASEAN ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY TETRACYCLINES, 2018-2032 (USD MILLION)
  • TABLE 228. ASEAN ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY ANIMAL SPECIES, 2018-2032 (USD MILLION)
  • TABLE 229. ASEAN ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2032 (USD MILLION)
  • TABLE 230. ASEAN ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 231. ASEAN ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 232. ASEAN ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 233. GCC ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 234. GCC ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY CLASS, 2018-2032 (USD MILLION)
  • TABLE 235. GCC ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY AMINOGLYCOSIDES, 2018-2032 (USD MILLION)
  • TABLE 236. GCC ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY BETA LACTAMS, 2018-2032 (USD MILLION)
  • TABLE 237. GCC ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FLUOROQUINOLONES, 2018-2032 (USD MILLION)
  • TABLE 238. GCC ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY MACROLIDES, 2018-2032 (USD MILLION)
  • TABLE 239. GCC ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY SULFONAMIDES, 2018-2032 (USD MILLION)
  • TABLE 240. GCC ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY TETRACYCLINES, 2018-2032 (USD MILLION)
  • TABLE 241. GCC ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY ANIMAL SPECIES, 2018-2032 (USD MILLION)
  • TABLE 242. GCC ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2032 (USD MILLION)
  • TABLE 243. GCC ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 244. GCC ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 245. GCC ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 246. EUROPEAN UNION ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 247. EUROPEAN UNION ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY CLASS, 2018-2032 (USD MILLION)
  • TABLE 248. EUROPEAN UNION ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY AMINOGLYCOSIDES, 2018-2032 (USD MILLION)
  • TABLE 249. EUROPEAN UNION ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY BETA LACTAMS, 2018-2032 (USD MILLION)
  • TABLE 250. EUROPEAN UNION ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FLUOROQUINOLONES, 2018-2032 (USD MILLION)
  • TABLE 251. EUROPEAN UNION ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY MACROLIDES, 2018-2032 (USD MILLION)
  • TABLE 252. EUROPEAN UNION ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY SULFONAMIDES, 2018-2032 (USD MILLION)
  • TABLE 253. EUROPEAN UNION ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY TETRACYCLINES, 2018-2032 (USD MILLION)
  • TABLE 254. EUROPEAN UNION ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY ANIMAL SPECIES, 2018-2032 (USD MILLION)
  • TABLE 255. EUROPEAN UNION ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2032 (USD MILLION)
  • TABLE 256. EUROPEAN UNION ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 257. EUROPEAN UNION ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 258. EUROPEAN UNION ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 259. BRICS ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 260. BRICS ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY CLASS, 2018-2032 (USD MILLION)
  • TABLE 261. BRICS ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY AMINOGLYCOSIDES, 2018-2032 (USD MILLION)
  • TABLE 262. BRICS ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY BETA LACTAMS, 2018-2032 (USD MILLION)
  • TABLE 263. BRICS ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FLUOROQUINOLONES, 2018-2032 (USD MILLION)
  • TABLE 264. BRICS ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY MACROLIDES, 2018-2032 (USD MILLION)
  • TABLE 265. BRICS ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY SULFONAMIDES, 2018-2032 (USD MILLION)
  • TABLE 266. BRICS ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY TETRACYCLINES, 2018-2032 (USD MILLION)
  • TABLE 267. BRICS ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY ANIMAL SPECIES, 2018-2032 (USD MILLION)
  • TABLE 268. BRICS ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2032 (USD MILLION)
  • TABLE 269. BRICS ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 270. BRICS ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 271. BRICS ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 272. G7 ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 273. G7 ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY CLASS, 2018-2032 (USD MILLION)
  • TABLE 274. G7 ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY AMINOGLYCOSIDES, 2018-2032 (USD MILLION)
  • TABLE 275. G7 ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY BETA LACTAMS, 2018-2032 (USD MILLION)
  • TABLE 276. G7 ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FLUOROQUINOLONES, 2018-2032 (USD MILLION)
  • TABLE 277. G7 ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY MACROLIDES, 2018-2032 (USD MILLION)
  • TABLE 278. G7 ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY SULFONAMIDES, 2018-2032 (USD MILLION)
  • TABLE 279. G7 ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY TETRACYCLINES, 2018-2032 (USD MILLION)
  • TABLE 280. G7 ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY ANIMAL SPECIES, 2018-2032 (USD MILLION)
  • TABLE 281. G7 ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2032 (USD MILLION)
  • TABLE 282. G7 ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 283. G7 ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 284. G7 ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 285. NATO ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 286. NATO ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY CLASS, 2018-2032 (USD MILLION)
  • TABLE 287. NATO ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY AMINOGLYCOSIDES, 2018-2032 (USD MILLION)
  • TABLE 288. NATO ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY BETA LACTAMS, 2018-2032 (USD MILLION)
  • TABLE 289. NATO ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FLUOROQUINOLONES, 2018-2032 (USD MILLION)
  • TABLE 290. NATO ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY MACROLIDES, 2018-2032 (USD MILLION)
  • TABLE 291. NATO ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY SULFONAMIDES, 2018-2032 (USD MILLION)
  • TABLE 292. NATO ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY TETRACYCLINES, 2018-2032 (USD MILLION)
  • TABLE 293. NATO ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY ANIMAL SPECIES, 2018-2032 (USD MILLION)
  • TABLE 294. NATO ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2032 (USD MILLION)
  • TABLE 295. NATO ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 296. NATO ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 297. NATO ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 298. GLOBAL ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 299. UNITED STATES ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 300. UNITED STATES ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY CLASS, 2018-2032 (USD MILLION)
  • TABLE 301. UNITED STATES ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY AMINOGLYCOSIDES, 2018-2032 (USD MILLION)
  • TABLE 302. UNITED STATES ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY BETA LACTAMS, 2018-2032 (USD MILLION)
  • TABLE 303. UNITED STATES ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FLUOROQUINOLONES, 2018-2032 (USD MILLION)
  • TABLE 304. UNITED STATES ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY MACROLIDES, 2018-2032 (USD MILLION)
  • TABLE 305. UNITED STATES ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY SULFONAMIDES, 2018-2032 (USD MILLION)
  • TABLE 306. UNITED STATES ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY TETRACYCLINES, 2018-2032 (USD MILLION)
  • TABLE 307. UNITED STATES ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY ANIMAL SPECIES, 2018-2032 (USD MILLION)
  • TABLE 308. UNITED STATES ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2032 (USD MILLION)
  • TABLE 309. UNITED STATES ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 310. UNITED STATES ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 311. UNITED STATES ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 312. CANADA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 313. CANADA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY CLASS, 2018-2032 (USD MILLION)
  • TABLE 314. CANADA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY AMINOGLYCOSIDES, 2018-2032 (USD MILLION)
  • TABLE 315. CANADA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY BETA LACTAMS, 2018-2032 (USD MILLION)
  • TABLE 316. CANADA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FLUOROQUINOLONES, 2018-2032 (USD MILLION)
  • TABLE 317. CANADA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY MACROLIDES, 2018-2032 (USD MILLION)
  • TABLE 318. CANADA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY SULFONAMIDES, 2018-2032 (USD MILLION)
  • TABLE 319. CANADA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY TETRACYCLINES, 2018-2032 (USD MILLION)
  • TABLE 320. CANADA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY ANIMAL SPECIES, 2018-2032 (USD MILLION)
  • TABLE 321. CANADA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2032 (USD MILLION)
  • TABLE 322. CANADA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 323. CANADA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 324. CANADA ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 325. MEXICO ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 326. MEXICO ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY CLASS, 2018-2032 (USD MILLION)
  • TABLE 327. MEXICO ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY AMINOGLYCOSIDES, 2018-2032 (USD MILLION)
  • TABLE 328. MEXICO ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY BETA LACTAMS, 2018-2032 (USD MILLION)
  • TABLE 329. MEXICO ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FLUOROQUINOLONES, 2018-2032 (USD MILLION)
  • TABLE 330. MEXICO ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY MACROLIDES, 2018-2032 (USD MILLION)
  • TABLE 331. MEXICO ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY SULFONAMIDES, 2018-2032 (USD MILLION)
  • TABLE 332. MEXICO ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY TETRACYCLINES, 2018-2032 (USD MILLION)
  • TABLE 333. MEXICO ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY ANIMAL SPECIES, 2018-2032 (USD MILLION)
  • TABLE 334. MEXICO ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2032 (USD MILLION)
  • TABLE 335. MEXICO ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 336. MEXICO ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 337. MEXICO ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 338. BRAZIL ANIMAL ANTIBIOTICS & ANTIMICROBIALS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 339. BRAZIL ANIMAL ANTIBI